Singapore markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
80.00+1.24 (+1.57%)
At close: 04:00PM EDT
80.35 +0.35 (+0.44%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 96.40B
Enterprise value 115.25B
Trailing P/E 21.24
Forward P/E 11.30
PEG Ratio (5 yr expected) 0.56
Price/sales (ttm)3.58
Price/book (mrq)4.54
Enterprise value/revenue 4.22
Enterprise value/EBITDA 13.02

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 335.18%
S&P500 52-week change 3-13.21%
52-week high 389.74
52-week low 357.17
50-day moving average 382.49
200-day moving average 373.63

Share statistics

Avg vol (3-month) 36.17M
Avg vol (10-day) 36.55M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.11%
% held by institutions 186.43%
Shares short (27 Feb 2023) 415.66M
Short ratio (27 Feb 2023) 42.25
Short % of float (27 Feb 2023) 41.26%
Short % of shares outstanding (27 Feb 2023) 41.26%
Shares short (prior month 30 Jan 2023) 415.17M

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 43.78%
Trailing annual dividend rate 32.92
Trailing annual dividend yield 33.71%
5-year average dividend yield 43.83
Payout ratio 480.22%
Dividend date 329 Mar 2023
Ex-dividend date 413 Mar 2023
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 16.83%
Operating margin (ttm)40.23%

Management effectiveness

Return on assets (ttm)10.46%
Return on equity (ttm)21.60%

Income statement

Revenue (ttm)27.28B
Revenue per share (ttm)21.74
Quarterly revenue growth (yoy)2.00%
Gross profit (ttm)21.62B
EBITDA 13.08B
Net income avi to common (ttm)4.59B
Diluted EPS (ttm)3.61
Quarterly earnings growth (yoy)329.30%

Balance sheet

Total cash (mrq)7.14B
Total cash per share (mrq)5.73
Total debt (mrq)25.81B
Total debt/equity (mrq)121.68
Current ratio (mrq)1.28
Book value per share (mrq)17.03

Cash flow statement

Operating cash flow (ttm)9.07B
Levered free cash flow (ttm)6.66B